Key result
miR-140-5p overexpression suppresses PASMC proliferation and migration to inhibit PAH pathogenesis via TNF-alpha targeting.
Why the study?
Pulmonary arterial hypertension is characterized by apoptosis resistance and hyperproliferation of pulmonary artery smooth muscle cells, but its pathogenesis has not been revealed, prompting investigation into the functions of miR-140-5p and TNF-alpha.
Does overexpression of miR-140-5p prevent pulmonary arterial hypertension progression by targeting TNF-alpha in rat models and hypoxia-mediated PASMCs?
Does overexpression of miR-140-5p prevent pulmonary arterial hypertension progression by targeting TNF-alpha in rat models and hypoxia-mediated PASMCs?
Answers are grounded in this paper and cite their sources.
Identifies the miR-140-5p/TNF-alpha axis as a key regulator of PASMC proliferation and migration in preclinical models, suggesting a potential therapeutic target for pulmonary arterial hypertension.
BACKGROUND: Pulmonary arterial hypertension (PAH) is characterized by the apoptosis resistance and hyperproliferation of pulmonary artery smooth muscle cells (PASMCs). Its pathogenesis has not been revealed. Here, we carried out experiments to investigate the functions of miR-140-5p and tumor necrosis factor-α (TNF-α). METHODS: We selected GSE703 from Gene Expression Omnibus (GEO) Database to conduct microarray analysis using R software and Gene Set Enrichment Analysis (GSEA). Combing bioinformatics results, the upregulation of miR-140-5p inhibited PAH progression through targeting TNF-α. RNA expression was measured by quantitative real-time polymerase chain reaction (RT-qPCR) and protein level was measured by western blot analysis and enzyme-linked immunosorbent assays (ELISA). We conducted monocrotaline (MCT) injection to rats to form PAH animal models. The lung tissues were observed by hematoxylin-eosin (HE) staining and Sirius red-picric acid staining. Right ventricular systolic pressure (RVSP) and the ratio of right ventricle (RV)-to-left ventricle (LV) plus septum (S) weight (RV/[LV + S]) were measured in MCT-induced animal models. Overexpression of miR-140-5p and TNF-α were utilized to research the proliferation, migration, and phenotypic variation of hypoxia-mediated PASMCs. The binding between miR-140-5p and TNF-α 3'-untranslated region (3'-UTR) was confirmed via luciferase reporter assay. RESULTS: Downregulation of miR-140-5p and upregulation of TNF-α were observed in PAH rat model and hypoxia-mediated PASMCs. And we proved that overexpression of miR-140-5p could suppress the proliferation, migration, and phenotypic variation of PASMCs, therefore inhibiting PAH pathogenesis. Luciferase assay verified that miR-140-5p targeted TNF-α directly. A converse correlation was also shown between miR-140-5p and TNF-α in PASMCs. CONCLUSIONS: miR-140-5p and TNF-α are important regulators in PAH pathology and may serve as a therapeutic target for PAH.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2018) studied Pulmonary arterial hypertension. Overexpression of miR-140-5p and TNF-alpha was evaluated on Proliferation, migration, and phenotypic variation of PASMCs, right ventricular systolic pressure (RVSP), and RV/(LV+S) weight ratio. Overexpression of miR-140-5p suppressed proliferation, migration, and phenotypic variation of PASMCs by directly targeting TNF-alpha, inhibiting PAH pathogenesis.
Synapse has enriched 10 related papers. Consider them for comparative context: